|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/12 | (2006.01) |
| A61K 31/48 | (2006.01) | ||
| A61K 9/72 | (2006.01) | ||
| A61P 25/06 | (2006.01) |
| (11) | Number of the document | 2425820 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11191794.4 |
| Date of filing the European patent application | 2008-02-11 | |
| (97) | Date of publication of the European application | 2012-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2015-04-08 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 900850 P | 2007-02-11 | US |
| (72) |
Cook, Robert, O., US
Shrewsbury, Stephen, B., US
Ramadan, Nabih, US
Armer, Thomas, A., US
|
| (73) |
MAP Pharmaceuticals Inc,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
| Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |